PerMed FH - Personalising diagnosis and treatment for Familial Hypercholeserolaemia patients

Who is PerMed FH For?

MORE THAN A SOLUTION FOR FH PATIENTS, THE EXTENDED VALUE OF PerMed FH

With PerMedFH patients with FH will be the ones that will most benefit from the innovative solution to improve patient management but the scientific/medical community and society will also benefit from this innovative initiative.

Patients & Families

Early detection through accurate genetic testing will pave the way for better management of FH and significantly improved outcomes.

Clinicians & Researchers

Get a better understanding of the mechanisms behind FH variants and improve the quality and efficacy of the condition’s management (from prevention to treatment).

world
Society

Improved detection and diagnosis of FH will uncover thousands living with this life-threatening condition unknowingly, enabling early treatment that prevents serious complications and saves lives.

The project leading to these results has received funding from “la Caixa” Foundation and FCT, I.P. under the project code: LCF/PR/HP23/52330032. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the "la Caixa" Foundation or the FCT. Neither "la Caixa" Foundation nor the FCT can be held responsible for them.
© 2026 - PerMed FH